Adult-onset Immunodeficiency in Thailand and Taiwan

Background: Autoantibodies against interferon-γ are associated with severe disseminated opportunistic infection, but their importance and prevalence are unknown.

Methods: We enrolled 203 persons from sites in Thailand and Taiwan in five groups: 52 patients with disseminated, rapidly or slowly growing, nontuberculous mycobacterial infection (group 1); 45 patients with another opportunistic infection, with or without nontuberculous mycobacterial infection (group 2); 9 patients with disseminated tuberculosis (group 3); 49 patients with pulmonary tuberculosis (group 4); and 48 healthy controls (group 5). Clinical histories were recorded, and blood specimens were obtained.

Results: Patients in groups 1 and 2 had CD4+ T-lymphocyte counts that were similar to those in patients in groups 4 and 5, and they were not infected with the human immunodeficiency virus (HIV). Washed cells obtained from patients in groups 1 and 2 had intact cytokine production and a response to cytokine stimulation. In contrast, plasma obtained from these patients inhibited the activity of interferon-γ in normal cells. High-titer anti-interferon-γ autoantibodies were detected in 81% of patients in group 1, 96% of patients in group 2, 11% of patients in group 3, 2% of patients in group 4, and 2% of controls (group 5). Forty other anticytokine autoantibodies were assayed. One patient with cryptococcal meningitis had autoantibodies only against granulocyte-macrophage colony-stimulating factor. No other anticytokine autoantibodies or genetic defects correlated with infections. There was no familial clustering.

Conclusions: Neutralizing anti-interferon-γ autoantibodies were detected in 88% of Asian adults with multiple opportunistic infections and were associated with an adult-onset immunodeficiency akin to that of advanced HIV infection. (Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research; ClinicalTrials.gov number, NCT00814827.).

Citing Articles

Serum IgE in the clinical features and disease outcomes of anti-interferon-γ autoantibodies syndrome.

Chen N, Liang H, Liang S, Liang X, Huang X, Yu Q BMC Immunol. 2025; 26(1):17.

PMID: 40057680 PMC: 11889914. DOI: 10.1186/s12865-025-00696-6.

Clinical Characteristics Analysis of 30 Cases of Interferon-γ Autoantibody-Positive Patients with Concurrent Mycobacterial Infection: A 6-Year Retrospective Study.

Zhao C, Song C, He H, Huang X, Meng X, Huang A Infect Drug Resist. 2025; 18:1097-1110.

PMID: 40027921 PMC: 11871848. DOI: 10.2147/IDR.S493956.

Clinical characteristics of acquired anti-IFN-γ autoantibodies in patients infected with non-tuberculous mycobacteria: a prospective cohort study.

Liang H, Liang S, Ning Y, Huang X, Ning R, Chen N BMC Pulm Med. 2025; 25(1):95.

PMID: 40016724 PMC: 11866636. DOI: 10.1186/s12890-025-03566-4.

Clinical manifestations in patients with anti-IFN-γ autoantibodies syndrome and Talaromyces marneffei infection: a prospective cohort study.

Liang H, Liang S, Wu S, Chen N, Huang X, Zeng Q BMC Infect Dis. 2025; 25(1):268.

PMID: 40000959 PMC: 11853739. DOI: 10.1186/s12879-025-10690-3.

Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area.

Yu X, Xu H, Zhou J, Zhu Z, Li B Front Oncol. 2025; 14():1407893.

PMID: 39834941 PMC: 11743283. DOI: 10.3389/fonc.2024.1407893.

References

Burbelo P, Ching K, Klimavicz C, Iadarola M . Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp. 2009; (32). PMC: 3164068. DOI: 10.3791/1549. View

Chetchotisakd P, Mootsikapun P, Anunnatsiri S, Jirarattanapochai K, Choonhakarn C, Chaiprasert A . Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis. 2000; 30(1):29-34. DOI: 10.1086/313589. View

Al-Muhsen S, Casanova J . The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008; 122(6):1043-51. DOI: 10.1016/j.jaci.2008.10.037. View

Sutherland R, Yang H, Scriba T, Ondondo B, Robinson N, Conlon C . Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. AIDS. 2006; 20(6):821-9. DOI: 10.1097/01.aids.0000218545.31716.a4. View

Patel S, Ding L, Brown M, Lantz L, Gay T, Cohen S . Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005; 175(7):4769-76. DOI: 10.4049/jimmunol.175.7.4769. View

Sungkanuparph S, Sathapatayavongs B, Pracharktam R . Infections with rapidly growing mycobacteria: report of 20 cases. Int J Infect Dis. 2003; 7(3):198-205. DOI: 10.1016/s1201-9712(03)90052-x. View

Kony S, Hane A, Larouze B, Samb A, Cissoko S, Sow P . Tuberculosis-associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar. SIDAK Research Group. J Infect. 2000; 41(2):167-71. DOI: 10.1053/jinf.2000.0721. View

Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S . Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005; 115(9):2480-8. PMC: 1190367. DOI: 10.1172/JCI19316. View

Browne S, Holland S . Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infect Dis. 2010; 10(12):875-85. DOI: 10.1016/S1473-3099(10)70196-1. View

10.

Ding L, Lai C, Lee L, Hsueh P . Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997-2003. Epidemiol Infect. 2006; 134(5):1060-7. PMC: 2870472. DOI: 10.1017/S0950268805005698. View

11.

van de Vosse E, Hoeve M, Ottenhoff T . Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis. 2004; 4(12):739-49. DOI: 10.1016/S1473-3099(04)01203-4. View

12.

Koya T, Tsubata C, Kagamu H, Koyama K, Hayashi M, Kuwabara K . Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother. 2009; 15(2):118-22. DOI: 10.1007/s10156-008-0662-8. View

13.

Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S . Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis. 2007; 45(4):421-7. DOI: 10.1086/520030. View

14.

Dorman S, Holland S . Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 2000; 11(4):321-33. DOI: 10.1016/s1359-6101(00)00010-1. View

15.

Baerlecken N, Jacobs R, Stoll M, Schmidt R, Witte T . Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis. 2009; 49(7):e76-8. DOI: 10.1086/605581. View

16.

Crum N, Lederman E, Wallace M . Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore). 2005; 84(5):291-302. DOI: 10.1097/01.md.0000180044.19285.9a. View

17.

Clark S, Page E, Ford T, Metcalf R, Pozniak A, Nelson M . Reduced T(H)1/T(H)17 CD4 T-cell numbers are associated with impaired purified protein derivative-specific cytokine responses in patients with HIV-1 infection. J Allergy Clin Immunol. 2011; 128(4):838-846.e5. DOI: 10.1016/j.jaci.2011.05.025. View

18.

Anekthananon T, Ratanasuwan W, Techasathit W, Rongrungruang Y, Suwanagool S . HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention. J Med Assoc Thai. 2004; 87(2):173-9. View

19.

Carey B, Trapnell B . The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010; 135(2):223-35. PMC: 2866141. DOI: 10.1016/j.clim.2010.02.017. View

20.

Hoflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Docke W . Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood. 2003; 103(2):673-5. DOI: 10.1182/blood-2003-04-1065. View